You are here

drug pricing

Community welcomes President Biden’s call to action to rein in high drug prices

MedCity News

Mon, 04/25/22 - 10:14 am

Why the drug pricing debate is focused on insulin

Pharmaforum

Wed, 04/13/22 - 10:48 am

$35 monthly insulin cap: Republicans decry how White House, Dems plan to pay for it

Endpoints

Thu, 03/31/22 - 10:35 am

U.S. Senate to Take Up Proposed $35 Insulin Cap this Spring

BioSpace

Mon, 03/28/22 - 07:54 pm

'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision

Endpoints

Mon, 03/28/22 - 10:08 am

Gilead Sciences

Cancer drug prices rise in the US despite an increasingly competitive market — report

Endpoints

Sun, 03/27/22 - 03:51 pm

Insulin price caps on the horizon as Senate leader plans vote

Pharmaforum

Wed, 03/23/22 - 10:33 am

Three big Congressional hearings next week to set the tenor on Covid-19, drug prices, and ARPA-H

Endpoints

Thu, 03/10/22 - 10:26 pm

Sanofi's net prices keep slipping—despite list price hikes—thanks to billions in rebates

Fierce Pharma

Wed, 03/2/22 - 10:12 pm

Biden continues his pledge for Medicare drug price negotiations in State of the Union speech

Endpoints

Wed, 03/2/22 - 09:57 am

Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharing

Fierce Pharma

Sun, 02/27/22 - 10:23 pm

Moderna Therapeutics

When the $10K brand name drug is more affordable than its $450 generic: How PBMs control the system

Endpoints

Sun, 02/20/22 - 11:52 am

FTC deadlocks on vote to launch study into PBM practices

BioPharma Dive

Fri, 02/18/22 - 10:33 am

FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies

Endpoints

Wed, 02/16/22 - 11:16 pm

A rarity for ICER: Cost watchdog says Covid-19 therapeutics appropriately priced in the US

Endpoints

Thu, 02/3/22 - 11:09 am

Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx

Fierce Pharma

Tue, 01/4/22 - 10:43 pm

Teva Pharmaceutical

Tales of the Unsurprised: Brand-Name Drug Prices Fell for the Fourth Consecutive Year

Drug Channels

Tue, 01/4/22 - 10:28 am

What’s Behind Biogen’s Move To Cut Prices On Its Controversial Alzheimer’s Drug Aduhelm?

Forbes

Sun, 12/26/21 - 11:16 pm

Alzheimer's disease

Biogen halves Aduhelm's price and plots cost cuts as Medicare decision on controversial Alzheimer's drug nears

Fierce Pharma

Mon, 12/20/21 - 11:11 am

Alzheimer's disease

Joe Manchin quashes any immediate hopes for major drug pricing reforms

Endpoints

Mon, 12/20/21 - 10:52 am

Build Back Better Act

Pages